We have isolated an isoform of the protein activator of lipoprotein lipase, apolipoprotein C-II, from the very low density lipoproteins of four patients of African ancestry with hypertriglyceridemia and eruptive or pedunculated xanthomata. This protein, which we designate apolipoprotein C-Il2, differs from the previously recognized species, which we denote apolipoprotein C-III, by substitution of glutamine for lysine at residue 55, a mutation which would require only a single-base substitution in the structural gene for apolipoprotein C-Il1. Each of the patients in whom apolipoprotein C-I12 was found had approximately equal amounts of apolipoprotein C-III and apolipoprotein C-I12 among the apoproteins of the very low density lipoproteins, suggesting that the structural genes for these proteins are allelic. Two additional apparent heterozygotes were found among the first-degree relatives of each of two of the patients in patterns compatible with monogenic autosomal transmission.
1. Abbreviations used in this paper: apo, apolipoprotein; CNBr, cyanogen bromide.
quencing of complementary DNA (cDNA) clones (6, 7) . We have previously reported the isolation of a second isoform of apo C-II from the protein moiety of human serum VLDL by preparative isoelectric focusing (8) . This isoform, which we designated apo C-IT2, gave a reaction ofidentity with the less anionic form of apo C-TI first isolated (apo C-IT1) in immunodiffusion.
We found that the two species activate lipoprotein lipase with equal potency.
We report here the primary structure of apo C-IT2 protein isolated from the plasma of three hyperlipemic subjects of African descent. This protein differs from apo C-TI1 by substitution ofa single mole ofglutamine for lysine at residue 55. This isoform is therefore a distinct structural gene product. The mutant gene, which could have been generated by either of two single-base exchanges, appears to be an allele of apo C-TI1, which is the predominant isoform in the Caucasian population. Apo C-TI2 is found in -12% of Americans of African ancestry.
Methods
Characterization ofpatients and normolipidemic subjects. In a survey of quantitative urea gel electrophoretograms (3) of the apolipoproteins of the lipoproteins of d < 1.006 g/cm3 in serum obtained from -500 hyperlipidemic individuals, four appeared to have one-half or less of the normal content of apo C-Il1. These samples showed prominent apo C-Il2 bands when the apo VLDL were subjected to isoelectric focusing (9) . All four patients had severe hyperlipemia, at least intermittently, and all had apo E phenotype E3/2 (10) . Their clinical characteristics are presented in Table I , and results ofdetailed analyses ofthe apolipoproteins of the d < 1.006 g/cm3 lipoproteins are shown in Table II . The distributions of the C-I12 trait and apo E phenotypes in the kindreds of two probands are presented in Fig. 1 . 50 black men and women without history of significant illness were recruited from among the students and staff of the University of California, San Francisco. Blood was drawn after the subjects had fasted overnight. The distribution ofcholesterol and triglycerides among VLDL, low density lipoproteins (LDL), and HDL was determined by preparative ultracentrifugation (1 1), and the distribution of apo E isoforms was determined by isoelectric focusing (9, 10 .g a0 Cleavage ofproteins with cyanogen bromide. Apo C-II species were dissolved in 70% formic acid and incubated with a 500-fold molar excess of cyanogen bromide (CNBr) (Sigma Chemical Co., St. Louis, MO), over methionine, for 24 h at 23°C (12) . The resulting fragments were Iyophilized, dissolved in 70% formic acid, and separated on a 0.6 X 120-cm column of polyacrylamide gel beads (P30, Bio-Rad Laboratories, Richmond, CA) in 25% formic acid. Three peaks were obtained as described by Jackson et al. (4) . Protein from the first peak was lyophilized in preparation for tryptic digestion. containing 0.02 NaN3 (pH 7.7) at an enzyme-protein ratio of 1:100 (wt/wt). Substrate proteins were present at a concentration of 5 mg/ml. Two-dimensional peptide mapping. Tryptic peptides were separated by thin-layer chromatography on cellulose (Merck & Co., Inc., Rahway, NJ) (13). 1-10 Il were applied to 10 X 10-cm sheets and chromatographed with isobutanol/pyridine/acetic acid/H20 (30:21:9:24). The plates were dried with warm air, sprayed with electrophoresis buffer (H20/pyridine/ acetic acid/isobutanol; 225:25:1:2), and subjected to electrophoresis at right angles to the chromatography, with a field potential of 500 V, at 6°C. Methyl green was used as a marker. The plates were air-dried and sprayed with a solution of 0.1 g of ninhydrin (Pierce Chemical Co., Rockford, IL) in 60 ml of ethanol, 20 ml of acetic acid, and 8 ml of collidine. Color of peptide spots was developed in 2-5 min at 80°C (14) .
Preparative thin-layer mapping. The preparative separation technique employed the same buffers, cellulose layers, and voltage described above, except that the plates were 20 X 20 cm. 40-60 ,l ofsolution were applied per plate. A concentration of ninhydrin one-tenth that used in mapping above was employed to minimize degradation of the peptides. Cellulose at each spot was scraped from the plates. The peptides were eluted with 0.02 M N-ethylmorpholine, pH 8.2, containing 0.02% NaN3 for amino acid analysis.
Amino acid analysis. Peptide samples were deaerated by alternate freezing and thawing in 6 N HCO (Ultrex, J. T. Baker Chemical Co., Phillipsburg, NJ), and hydrolyzed in vacuo for 22 The apo C-I12 gene and the apo E2 gene did not cosegregate in the two patients' kindreds that were available for study (Fig. 1 ).
It is probable that these genes are present on separate chromosomes, most likely members of a homologous pair, because the structural genes for both apo E and apo C-I1, have been mapped to chromosome 19 (4) . However, a nonallelic site for the apo C-I12 structural gene is equally compatible with these patterns of transmission.
Maps of tryptic peptides of apo C-I11 contained seven distinct ninhydrin-reactive spots which we designate A-G (Fig. 2) . In contrast, the peptides designated D and F were absent from maps of apo C-I42 (Fig. 2) . Identical maps were obtained with apo C-I2 from patients 1-3, described above, who ha emia associated with partial deficiency ofapo C-III analysis of the peptides recovered from the prepa mensional plates allowed us to establish their iden erence to the tryptic peptides described by Jackson 3, Table III ). In our experiments cleavage appar occur at the lysine at residue 76, so that the seq sponding to peptides 7 and 8 of Jackson et al. rn joined. In the case of apo C-I1, the A peptide, M at the point of application to the thin-layer plate appropriate molar ratios of amino acids for the ca tides 7 and 8 (residues 56-79). Our peptide D ca peptide T-6 and our peptide F corresponds to thi residues 49-55, or peptides T-5 and T-6 conjoinc failure to cleave at the arginine residue at positic and 3; Table III ). In the case of apo C-IT2, a reduc C-11-2 peptide T-5 was seen and peptides T-6, T-7, and T- CNBr I fragment of apo C-II2 also contained peptide H, indicating that these regions are similar in the two isoforms. However, peptide I was missing and two different peptides designated J and K appeared. Amino acid analysis of these peptides (Table   IV) showed that peptide J could be identified as the T-6 peptide, plus the I segment (residues 51-60 overall) and peptide K as the equivalent of T-5, T-6, and the I segment (residues 49-60 overall), except that each contained one residue of glutamate and essentially no lysine. This is again evidence for substitution of glutamic acid or glutamine for lysine somewhere between residues 49 and 60. To determine whether glutamic acid or glutamine is the substituted element, we subjected peptides J and K to enzymic hydrolysis which, in contrast to acid hydrolysis, would not remove the amide group from glutamine. This resulted in the appearance of an additional mole of amino acid at the point where serine normally appears, and where we found glutamine to be eluted when it is chromatographed by our analyzer program. We therefore conclude that substitution of glutamine for lysine at position 55 is the cause of the polymorphism of apo C-II described here.
All ofthe 50 control subjects were normolipidemic. Six were found to have bands corresponding to apo C-IIT and apo C-II2 of equal intensity on isoelectric focusing of the apolipoproteins of VLDL. Of the remainder 42 had no visible apo C-II2 band and two had only traces of a band with appropriate pI for apo C-12. The total serum cholesterol and triglyceride levels and the cholesterol and triglyceride contents of ultracentrifugal fractions of serum in the apo C-II, and C-I42 groups are shown in Table V . No significant differences were found in any of these values. In comparison with the four hyperlipidemic patients with C-II2 heterozygosity, all of whom had the E3/2 phenotype, only one of the six normolipidemic subjects with C-IT2 had the E3/2 phenotype. One had E4/3 and the remainder E3/3. This distribution of phenotypes is consistent with gene frequencies for the apo E alleles in Caucasian populations (18) .
Discussion
Substitution of glutamine for lysine is a mutation which would require only a single-base exchange in the structural gene for the protein. Because the codes for both lysine and glutamine are degenerate, either mutation AAA -CAA or AAG -CAG produces the structural change that we have observed. The observation that the levels of apo C-IH1 appear to be half of normal or less in these subjects is consistent with the simplest genetic model, in that the genes for the isoforms are allelic. However, an additional genetic circumstance could account for the observed distribution of isoforms. That is, there may be nonallelic genes governing the synthesis of the C-I12 isoform of this apolipoprotein, analogous to those for the -y-chains of fetal hemo- globin (19, 20) . These additional genes, which code for proteins differing from the principal gene product by a single-point substitution, contribute increased amounts of y-chain in the face of anemia. The expression of such nonallelic genes might be called forth when the synthesis of the normal C-II isoform is curtailed by some primary genetic or metabolic process. Such a mechanism is consistent with the observation that trace amounts of apoprotein with an isoelectric point indistinguishable from that of C-I12 protein occasionally appear in apo VLDL. Our previous observation tht the C-I12 apoprotein possesses normal ability to activate lipoprotein lipase was made on protein isolated from the VLDL of patient 3 (8) . Therefore, it appears that lysine residue 55 is not critical to the activation of the lipoprotein lipase system, despite evidence that this residue is included in a segment ofthe protein in which the activator property residues (2 1).
The total content of apo C-II appears to be diminished in the VLDL of our hyperlipidemic patients, as it is in most hypertriglyceridemic subjects (22) . Whether the resulting change in ratios of apo C-II to apo C-III or other apolipoproteins might have an influence on triglyceride clearance in vivo is unknown. Conceivably, apo C-II has other roles independent of its relationship to lipoprotein lipase, in which apo C-12 may not function normally. Three of our affected patients had one or more of the clinical risk factors for hyperlipidemia, such as marked obesity or glucose intolerance. It is of interest that all four of the hyperlipidemic patients with apo C-12 had the apolipoprotein E phenotype E3/2. This phenotype could have influenced the expression of hyperlipidemia in these patients.
Our finding of apparent heterozygosity for apo C-I1, and C-I12 in -12% of normolipidemic black adults suggests that this is a common trait among individuals of African descent and that it does not appear to be, by itself, a determinant of hyperlipidemia. Whether in the presence of other etiologic factors it could participate in the genesis of hyperlipidemia will require further studies. Perhaps, as with hemoglobin S and some other protein polymorphisms, there has been some positive selection pressure favoring this mutation among Africans, perhaps even relating to one of the roles of lipoproteins that does not involve the transport of triglycerides or cholesterol.
